DailyIQ
Last updated 1 hour ago

VTR·Ventas, Inc.

$.
+. (+.%)
High
$89.68
Open
$89.04
Market Cap
42.75B
52W High
$91.06
Low
$88.19
P. Close
$88.18
P/E
164.15
52W Low
$61.76
Fwd P/E
104.15
Mean Target
-
Technical Score (1D)
91
BUY
News Sentiment
60
BULLISH
Analysts are showing increased confidence in Ventas (VTR) as two firms, Baird and Mizuho, have recently raised their price targets to $98, maintaining Outperform ratings. This positive analyst sentiment suggests a belief in VTR's continued performance and potential upside. Earlier, Scotiabank also adjusted its view, raising the price target to $95 while reiterating a Sector Perform rating. These target increases reflect an updated analyst assessment of the healthcare REIT's valuation and market position. Investors should watch for any further commentary from these analysts regarding the broader healthcare REIT landscape. The consistent upward revisions in price targets, even with a Sector Perform rating from Scotiabank, indicate a generally favorable outlook for VTR in the near term.
Earnings Summary
Ventas, Inc. is a real estate investment trust (REIT) specializing in properties catering to an aging demographic, with a portfolio of approximately 1,400 senior housing communities, outpatient medical facilities, and other healthcare-related properties across North America and the United Kingdom. Operating within the "longevity economy," Ventas focuses on providing essential services and environments designed to enhance the well-being of its residents, leveraging data-driven insights and industry relationships. The company's sector is Real Estate, specifically within Healthcare Facilities REITs. Examining recent performance, Ventas reported actual EPS of $0.94 for Q1 2026, exceeding the estimate of $0.10, and revenue of $1.66 billion, surpassing the estimate of $1.58 billion. This follows a Q4 2025 where actual EPS was $0.89 against an estimate of $0.0848, with revenue at $1.57 billion versus an estimate of $1.52 billion. Prior to these quarters, the company showed a pattern of actual EPS beating estimates in Q3 2025 ($0.12097 vs $0.05), Q2 2025 ($0.15 vs $0.13582), and Q1 2025 ($0.10 vs $0.07363), though Q4 2024 saw actual EPS of $0.13 against an estimate of $0.05066. Revenue figures are available from Q4 2025 onwards, showing consistent growth. Historically, Ventas has demonstrated a strong year-over-year growth trajectory, particularly in its most recent reported quarters. The company has a notable pattern of exceeding analyst expectations for both earnings per share and revenue in its latest reported periods, indicating a positive performance trend. This consistent outperformance suggests effective operational management and favorable market conditions within its specialized real estate segments. Recent news highlights analyst confidence in Ventas, with projections for Q1 earnings indicating year-over-year increases in both EPS and revenue, supported by upward revisions in EPS estimates. Developments such as lease renewals and property developments in the industrial sector, alongside strategic property sales for optimization, suggest ongoing operational activity. Furthermore, significant stock appreciation over the past six months, driven by demand in the senior housing sector and strategic investments, alongside increased institutional confidence, points to positive market sentiment and a substantial investment pipeline for 2026. Looking ahead, investors will be watching for continued strong performance in Ventas's senior housing and medical office building segments, with occupancy rates and rental income trends being key indicators. The company's ability to sustain its recent momentum and effectively deploy its projected $2.50 billion investment pipeline for 2026 will be critical factors to monitor in upcoming quarters.

EPS

EstBeatMiss
$-0.08$0.21$0.49$0.78$1.07Q1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$0.10$0.94+840.0%
Q4'25$0.08$0.89+949.5%
Q3'25$0.05$0.12+141.9%
Q2'25$0.14$0.15+10.4%
Q1'25$0.07$0.10+35.8%

Revenue

EstBeatMiss
$1.3B$1.4B$1.5B$1.6B$1.7BQ1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$1.6B$1.7B+5.1%
Q4'25$1.5B$1.6B+2.9%
Q3'25 - $1.5B -
Q2'25 - $1.4B -
Q1'25 - $1.4B -

Market Data

VTR Stock Snapshot

VTR is currently trading at $88.96, giving Ventas, Inc. a market cap of 42.75B and a P/E ratio of 164.2. Today's range spans $88.19–$89.68, with shares opening at $89.04 and moving up $0.78 (0.9%) from the prior close. DailyIQ's technical score sits at 91/100 (BUY) with a news sentiment reading of 60/100.

Over the past year VTR has traded between $61.76 and $91.06 - the current price is +44.0% off the 52-week low and -2.3% from the high.

The earnings revision cycle for Ventas, Inc. (VTR) may be in an upward phase - large-cap Real Estate names (42.75B market cap) showing bullish technicals (91/100, BUY) alongside bullish sentiment (60/100) often see analyst target increases in the weeks following this kind of dual-signal alignment. Price: $88.96 (near 52-week highs). (P/E: 164.2) Range: $61.76–$91.06. The chart frequently leads the fundamental revision, and the chart is bullish.

Earnings revision cycles in large-cap Real Estate names tend to compound: when technicals confirm a BUY thesis (91/100) and news sentiment (60/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $88.96 (near 52-week highs), VTR's position within the $61.76–$91.06 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…